These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia. Okada M; Ueda H; Kometani M; Nakao K; Kohjimoto Y; Takahashi I; Tanaka I Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445 [TBL] [Abstract][Full Text] [Related]
10. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360 [TBL] [Abstract][Full Text] [Related]
11. Effect of low-affinity NMDA receptor antagonists on electrical activity in mouse cortical slices. Naish HJ; Marsh WL; Davies JA Eur J Pharmacol; 2002 May; 443(1-3):79-83. PubMed ID: 12044795 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of functional antagonists at the glycine site of the NMDA receptor. Trullas R Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():55-6. PubMed ID: 9403859 [No Abstract] [Full Text] [Related]
13. [Inefficacy of N-methyl-D-aspartate receptor complex antagonists on behavioral and histologic consequences of global cerebral ischemia in rats]. Allaf R; Vistelle R; Boulu RG Ann Pharm Fr; 2000 Jul; 58(4):266-70. PubMed ID: 10915975 [TBL] [Abstract][Full Text] [Related]
14. Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist. Moe ST; Smith DL; DelMar EG; Shimizu SM; Van Wagenen BC; Balandrin MF; Chien YE; Raszkiewicz JL; Artman LD; White HS; Mueller AL Bioorg Med Chem Lett; 2000 Nov; 10(21):2411-5. PubMed ID: 11078190 [TBL] [Abstract][Full Text] [Related]
15. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity. Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Pringle AK; Iannotti F; Wilde GJ; Chad JE; Seeley PJ; Sundstrom LE Brain Res; 1997 Apr; 755(1):36-46. PubMed ID: 9163539 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Lea PM; Movsesyan VA; Faden AI Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750 [TBL] [Abstract][Full Text] [Related]
18. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors. Widdowson PS; Gyte AJ; Upton R; Wyatt I Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia. Hicks CA; Ward MA; Ragumoorthy N; Ambler SJ; Dell CP; Dobson D; O'Neill MJ Brain Res; 1999 Feb; 819(1-2):65-74. PubMed ID: 10082862 [TBL] [Abstract][Full Text] [Related]
20. The rationale for glutamate antagonists in the treatment of traumatic brain injury. Myseros JS; Bullock R Ann N Y Acad Sci; 1995 Sep; 765():262-71; discussion 298. PubMed ID: 7486612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]